Pentasa Sachet 2 g depotgranulat, Pentasa PLACEBO Sachet 2g in the granule formulation specifically designed to resemble the active drug product
Phase 2 small_molecule active
Quick answer
Pentasa Sachet 2 g depotgranulat, Pentasa PLACEBO Sachet 2g in the granule formulation specifically designed to resemble the active drug product for Lynch syndrome, which is increasing the risk of developing colorectal cancer is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Lynch syndrome, which is increasing the risk of developing colorectal cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active